Does AMBRISENTAN Cause Interstitial lung disease? 164 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Interstitial lung disease have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.2% of all adverse event reports for AMBRISENTAN.
164
Reports of Interstitial lung disease with AMBRISENTAN
0.2%
of all AMBRISENTAN reports
49
Deaths
73
Hospitalizations
How Dangerous Is Interstitial lung disease From AMBRISENTAN?
Of the 164 reports, 49 (29.9%) resulted in death, 73 (44.5%) required hospitalization, and 13 (7.9%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which AMBRISENTAN Alternatives Have Lower Interstitial lung disease Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE